It is purposed to verify a superiority of the Fastseal® Bioabsorbable Vascular Access Closure
System through effectiveness and safety confirmation of hemostasis (TTH; Time to hemstasis)
and ambulation (TTA; Time to ambulation) at the puncture site of common femoral artery (CFA)
after the procedures of Fastseal® Biosorbable Vascular Access Closure System or Perclose®
ProGlide Suture-Mediated Closure System during 1 month observation.